Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

This study has been terminated.
(slow enrollment , interim analysis conducted.)
Information provided by:
Vitreoretinal Technologies, Inc. Identifier:
First received: April 18, 2008
Last updated: October 19, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)